Astra pursues stroke drug despite mixed results (Reuters)


Reuters - AstraZeneca Plc will press ahead with
final-stage clinical trials of Cerovive, an experimental
treatment for strokes, after mixed results from one study,
Europe's third-biggest drugmaker said on Wednesday.

Read more...